Compositions and methods for viral sensitization
US-2024360115-A1 · Oct 31, 2024 · US
US11795147B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11795147-B2 |
| Application number | US-202017002937-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 26, 2020 |
| Priority date | Aug 26, 2019 |
| Publication date | Oct 24, 2023 |
| Grant date | Oct 24, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention describes compounds modulating the function of mitochondrial complex I (NADH-quinone oxidoreductase) having formula (I)
Opening claim text (preview).
The invention claimed is: 1. A compound having formula (I) or a salt thereof wherein: R1 is C 1-4 -alkyl unsubstituted or substituted with MeO; tetrahydropyranyl, tetrahydrofuranyl, oxetanyl, dioxepanyl, pyrrolidinyl or piperidinyl; or pyrrolidinyl or piperidinyl with the nitrogen substituted by methyl, isopropyl, oxetanyl, ethoxycarbonyl, acetyl, or trifluoroacetyl; R2 is a 5-, 6- or 7-membered ring containing 1 or 2 heteroatoms selected from O or N bound in formula (I) by a C═C double bond, in which one or both N-atoms can be substituted by methyl, isopropyl, acetyl, benzyloxycarbonyl, phenyl, oxetanyl or tetrahydropyranyl, and in which one or more C-atoms can be substituted by -methyl or —OH; R3 and R4 are independently from one another hydrogen; C 1-6 -alkyl, unsubstituted or substituted with one or more F, methoxy, C 3-8 -cycloalkyl unsubstituted or substituted with one or more F; aryl; heteroaryl consisting of 5 to 6 ring atoms; or heterocyclyl selected from the group consisting of oxetanyl, tetrahydropyranyl and pyrrolidinyl, said heterocyclyl being unsubstituted or substituted with C 1-6 -alkyl, acetyl, tetrahydrofuranyl, oxetanyl or hydroxyethylacetyl; or R3 and R4 together with the attached N form a heterocyclyl ring selected from the group consisting of morpholinyl and pyrrolidinyl both unsubstituted or substituted with C 1-6 -alkyl, F, or hydroxyl; or R3 and R4 together represent one of the following groups: 2. A compound selected from the group consisting of the following compounds 1 to 175, or a salt thereof: # Structure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
2-Pyrrolones · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Bridged systems · CPC title
with only one oxygen atom as ring hetero atom in the oxygen-containing ring · CPC title
Spiro-condensed systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.